SCHEMBL23155304

SCHEMBL23155304

c1ccc(-c2ccccc2N(c2ccc3c(c2)-c2c4cccc2-c2cccc-3c2-c2ccccc2-4)c2cccc3oc4ccccc4c23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 1/20 0.33
▸ CDC14A Q9UNH5 1/20 0.33
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ TNKS O95271 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ABCB1 P08183 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ PARP1 P09874 1/20 0.30
▸ ADORA3 P0DMS8 1/20 0.30
▸ AR P10275 1/20 0.30
▸ CYP19A1 P11511 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155322 0.92 PLA2G2A (0.33) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL23155234 0.91 PLA2G2A (0.32) CDC14BCDC14AGABRPGABRDNPC1
SCHEMBL23155282 0.89 ALOX5 (0.32) —
SCHEMBL23155228 0.88 NPC1 (0.35) GABRPGABRDNPC1CA12TNKS
SCHEMBL23155227 0.88 MEN1 (0.35) GABRPGABRDNPC1CA12TNKS
SCHEMBL23155230 0.87 ALOX5 (0.39) CDC14BCDC14A
SCHEMBL23155358 0.87 L3MBTL1 (0.33) HPGD
SCHEMBL25580843 0.87 ALOX5 (0.32) CDC14BCDC14AGABRPGABRDNPC1
SCHEMBL23155336 0.87 ALOX5 (0.32) —
SCHEMBL25580544 0.87 CDC14B (0.32) CDC14BCDC14ATNKSCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 CDC14B 2875/4885CDC14A 3414/4885GABRP 4828/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 CDC14B 2875/4885CDC14A 3414/4885GABRP 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback